Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The claims presented match the supplied FDA label language for complex sleep behaviors, including timing (first or any subsequent use), examples, potential severity (serious injury/death), amnesia, and occurrence with or without alcohol/CNS depressants. A minor omission is the label’s instruction to discontinue immediately if complex sleep behaviors occur.
Category Scores
Accurate Statements
AMBIEN may cause complex sleep behaviors (e.g., sleep-walking, sleep-driving, and other activities while not fully awake).
Supported by 5.1 (Complex Sleep Behaviors) which lists sleep-walking, sleep-driving, and other activities while not fully awake.
Complex sleep behaviors can result in serious injury or death.
Supported by 5.1 (Complex Sleep Behaviors) stating patients can be seriously injured or injure others and such injuries may result in a fatal outcome.
Complex sleep behaviors may occur after the first or any subsequent use (dose).
Supported by 5.1 (Complex Sleep Behaviors) stating may occur following the first or any subsequent use.
Complex sleep behaviors may occur with or without alcohol or other CNS depressants.
Supported by 5.1 (Complex Sleep Behaviors) stating postmarketing reports show occurrence with AMBIEN alone at recommended doses, with or without concomitant alcohol or other CNS depressants; and supported by 7.1 (CNS-Active Drugs) in the alcohol/CNS depressant context.
Patients usually do not remember these events.
Supported by 5.1 (Complex Sleep Behaviors) stating patients usually do not remember these events.
Unsupported Statements
Contradictions
Important Omissions
The label’s instruction to discontinue AMBIEN immediately if a patient experiences a complex sleep behavior.
Importance:
Low
Safety Assessment
Potential Patient Risk:
Low
Core risk description for complex sleep behaviors is supported by the label; the main gap is omission of the label’s immediate discontinuation instruction, which slightly reduces label-concordant safety guidance.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Omission of the label directive to discontinue AMBIEN immediately if complex sleep behaviors occur.
Suggested Improvement
Add: Discontinue AMBIEN immediately if a complex sleep behavior occurs (per 5.1 and cross-reference in 4).